BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28936272)

  • 21. Mainstreaming genetic counseling for
    Verma A; Nag S; Hasan Q; Selvakumar VPP
    Indian J Cancer; 2019 Nov; 56(Supplement):S38-S47. PubMed ID: 31793441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The joint JMA-JICA project in Nepal.
    Kuratsuji T
    Acta Paediatr Jpn; 1993 Dec; 35(6):571-5. PubMed ID: 8109243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation.
    Garg K; Karnezis AN; Rabban JT
    Pathology; 2018 Feb; 50(2):238-256. PubMed ID: 29373116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
    Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Information needs of women undergoing gynaecological risk reduction surgery: Applying patient-reported findings to improve service delivery.
    Jennings B; Ramis MA; Kynoch K; Jagasia N
    Aust N Z J Obstet Gynaecol; 2022 Apr; 62(2):286-293. PubMed ID: 34751946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The supportive care needs of women experiencing gynaecological cancer: a Western Australian cross-sectional study.
    Williams N; Griffin G; Farrell V; Rea A; Murray K; Hauck YL
    BMC Cancer; 2018 Sep; 18(1):912. PubMed ID: 30241476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Country focus -- Nepal. Making motherhood safer in Nepal.
    Safe Mother; 1995 Feb; (16):3, 9. PubMed ID: 12319472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mainstreaming oncogenomics model: improving the identification of Lynch syndrome.
    O'Shea R; Crook A; Jacobs C; Kentwell M; Gleeson M; Tucker KM; Hampel H; Rahm AK; Taylor N; Lewis S; Rankin NM
    Front Oncol; 2023; 13():1140135. PubMed ID: 37305562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast Cancer in Nepal: Current status and future directions.
    Giri M; Giri M; Thapa RJ; Upreti B; Pariyar B
    Biomed Rep; 2018 Apr; 8(4):325-329. PubMed ID: 29541453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.